Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Trial Tentatively Backs DOACs After TAVR

(MedPage Today) -- In a departure from other transcatheter aortic valve replacement (TAVR, or TAVI) trials, direct oral anticoagulant (DOAC, or NOAC) therapy seemed to safely prevent subclinical leaflet thrombosis in ACASA-TAVI -- but not convincingly...

Trial Tentatively Backs DOACs After TAVR

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 31 August →